CLX Clorox Co

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Marriner Kirsten	2. Issuer Name and Ticker or Trading Symbol CLOROX CO /DE/ [ CLX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) EVP - Chief People Officer
(Last)          (First)          (Middle) 1221 BROADWAY	3. Date of Earliest Transaction (MM/DD/YYYY) 11/18/2020
(Street) OAKLAND, CA 94612-1888 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2020		M(1)		24560.0000	A	$123.0900	32666.0000	D
Common Stock	11/18/2020		M(1)		22380.0000	A	$125.9400	55046.0000	D
Common Stock	11/18/2020		M(1)		18427.0000	A	$135.5700	73473.0000	D
Common Stock	11/18/2020		S(1)		62206.0000	D	$210.0000	11267.0000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$125.9400	11/18/2020		M			22380.0000	3/14/2017	3/14/2026	Common Stock	22380.0000	$0.0000	0.0000	D
Stock Option (Right to Buy)	$135.5700	11/18/2020		M			18427.0000	9/12/2018	9/12/2027	Common Stock	18427.0000	$0.0000	6143.0000	D
Stock Option (Right to Buy)	$123.0900	11/18/2020		M			24560.0000	9/13/2017	9/13/2026	Common Stock	24560.0000	$0.0000	0.0000	D

Explanation of Responses:
(1)	Transaction executed pursuant to a pre-planned trading program adopted by reporting person on August 19, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Marriner Kirsten 1221 BROADWAY OAKLAND, CA 94612-1888			EVP - Chief People Officer

Signatures
By Cheryl Brice, Attorney-in-Fact for		11/20/2020
**Signature of Reporting Person		Date